Example: tourism industry
ANEXO I FICHA TÉCNICA O RESUMEN DE LAS …
2 1. NOMBRE DEL MEDICAMENTO Plavix 75 mg comprimidos recubiertos con película Plavix 300 mg comprimidos recubiertos con película …
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
FIBRILAÇÃO ATRIAL CRÔNICA, AVC E …
www.scielo.brArq Neuropsiquiatr 2004;62(4) 1019 rados pouco aderentes ao uso de warfarina pela condição sócio-econômica. Os pacientes que foram. N
Farmacología de los antitrombóticos - Medigraphic
www.medigraphic.com26 Gac Méd Méx Vol. 143 Supl 1, 2007 orales, la acenocumarina y la warfarina. 2 Las diferencias entre ambas son farmacocinéticas; la primera tiene una vida media y duración de acción menor.
Alho - Ecoverde Mudas Nativas
ecoverdemt.com.br2 de bronquite, tuberculose, diminui a tosse, provoca a expectoração. Pode ser utilizado também em ferimentos e cortes de prego enferrujado, espinhos,
LO QUE CONVIENE SABER A TODO …
www.apam-malaga.orgLO QUE CONVIENE SABER A TODO ANTICOAGULADO SOBRE EL I.N.R. El I.N.R. son las siglas de las palabras “Razón Normalizada Internacional” (en inglés, “International Normalized Ratio”), término adoptado por la Organización
OMNIC TAMSULOSINA 0,4 mg - gador.com.ar
www.gador.com.arOMNIC TAMSULOSINA 0,4 mg Venta bajo receta Industria Holandesa Cápsulas de liberación controlada COMPOSICIÓN CUALI-CUANTITATIVA Cada capsula de liberación controlada de Omnic®contiene:
Interacciones farmacocinéticas. Interacciones ...
www.granadafarmaceutica.comA FONDO POTENCIADORES INHIBIDORES NO INTERFERENCIA Altiulcerosos - Cimetidina - Omeprazol - Sucralfato - Pantoprazol (Se considera alternativa al omeprazol)
TROMBOSIS VENOSA PROFUNDA - medigraphic.com
www.medigraphic.comVASCULAR REVISTA MEDICA DE COSTA RICA Y CENTROAMERICA LXXI (612) 715 - 718, 2014 SUMMARY This review includes the etiology, pathology, diagnosis
Vasculitis Leucocitoclásticas - SVR
www.svreumatologia.comCapítulo 16: Vasculitis Leucocitoclásticas 291 semida, hidroclorotiacida, espironolactona, clor-talidona), beta-bloqueantes, captopril, diltiazem,